• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[前列腺癌雄激素非依赖性进展的机制]

[Mechanism on androgen-independent progression of prostate cancer].

作者信息

Shimazaki J, Akakura K, Furuya Y, Ito H

机构信息

Department of Urology, School of Medicine, Chiba University.

出版信息

Nihon Rinsho. 1997 May;55(5):1143-8.

PMID:9155166
Abstract

Eighty percent of prostate cancer with metastasis respond to androgen ablasion, showing initial androgen-sensitive growth. However, more than half of responders gradually loses dependency up to 5 years. Animal experiments reveal that loss of androgen sensitivity is attributable to complex reasons; adaptation, paracrine control by other androgen-independent tissues, genetic changes and mutation of androgen receptor. Most important event is explained from alteration of expression on oncogenes and suppressor genes. Counterplan of the progression was discussed.

摘要

80%发生转移的前列腺癌对雄激素剥夺有反应,表现出初始的雄激素敏感性生长。然而,超过一半的反应者在5年内会逐渐失去依赖性。动物实验表明,雄激素敏感性丧失归因于复杂的原因;包括适应性、其他雄激素非依赖性组织的旁分泌控制、基因变化以及雄激素受体的突变。最重要的事件可从癌基因和抑癌基因表达的改变来解释。文中还讨论了针对该进展的应对方案。

相似文献

1
[Mechanism on androgen-independent progression of prostate cancer].[前列腺癌雄激素非依赖性进展的机制]
Nihon Rinsho. 1997 May;55(5):1143-8.
2
Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer.原发性进展时雄激素受体基因扩增可预测晚期前列腺癌二线治疗中联合雄激素阻断的疗效。
J Urol. 2000 Dec;164(6):1992-5.
3
Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence.前列腺癌细胞雄激素剥夺的纵向分析确定了雄激素非依赖途径。
Prostate. 2008 May 15;68(7):698-714. doi: 10.1002/pros.20677.
4
Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer.鉴定μ-晶状体蛋白为人类前列腺癌中的雄激素调节基因。
Prostate. 2009 Jul 1;69(10):1109-18. doi: 10.1002/pros.20956.
5
Androgens, androgen receptors, antiandrogens and the treatment of prostate cancer.雄激素、雄激素受体、抗雄激素药物与前列腺癌的治疗
Eur Urol. 1997;32 Suppl 3:24-40.
6
Evolution of the androgen receptor pathway during progression of prostate cancer.前列腺癌进展过程中雄激素受体通路的演变
Cancer Res. 2006 May 15;66(10):5012-20. doi: 10.1158/0008-5472.CAN-05-3082.
7
Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.雄激素剥夺诱导侵袭性激素难治性前列腺癌克隆的选择性生长,这些克隆表达亲代雄激素依赖性癌细胞中不存在的独特细胞和分子特性。
Cancer J. 2000 Jul-Aug;6(4):220-33.
8
[Mechanism of loss of androgen dependency in androgen-dependent tumor].[雄激素依赖性肿瘤中雄激素依赖性丧失的机制]
Hum Cell. 1993 Sep;6(3):170-5.
9
Mechanisms of prostate cancer progression to androgen independence.前列腺癌进展为雄激素非依赖性的机制。
Best Pract Res Clin Endocrinol Metab. 2008 Apr;22(2):373-88. doi: 10.1016/j.beem.2008.02.006.
10
Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.雄激素受体依赖性Bcl-xL表达调控:对前列腺癌进展的影响。
Prostate. 2008 Mar 1;68(4):453-61. doi: 10.1002/pros.20723.